Does EMPAGLIFLOZIN\LINAGLIPTIN Cause Off label use? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Off label use have been filed in association with EMPAGLIFLOZIN\LINAGLIPTIN. This represents 1.7% of all adverse event reports for EMPAGLIFLOZIN\LINAGLIPTIN.
28
Reports of Off label use with EMPAGLIFLOZIN\LINAGLIPTIN
1.7%
of all EMPAGLIFLOZIN\LINAGLIPTIN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Off label use From EMPAGLIFLOZIN\LINAGLIPTIN?
Of the 28 reports, 11 (39.3%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN\LINAGLIPTIN. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN\LINAGLIPTIN Cause?
Diabetic ketoacidosis (149)
Blood glucose increased (121)
Fungal infection (92)
Weight decreased (77)
Nausea (68)
Dizziness (58)
Vomiting (55)
Urinary tract infection (52)
Euglycaemic diabetic ketoacidosis (49)
Dehydration (44)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMPAGLIFLOZIN\LINAGLIPTIN Alternatives Have Lower Off label use Risk?
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL